| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 15.074 | 272.538 | 269.213 | 250.430 | 247.252 | 339.364 | 400.894 | 465.229 | 603.268 |
| Total Income - EUR | - | 15.074 | 272.765 | 269.241 | 252.559 | 257.571 | 339.631 | 400.894 | 479.455 | 612.871 |
| Total Expenses - EUR | - | 7.806 | 193.022 | 239.065 | 200.722 | 185.176 | 257.442 | 280.704 | 304.830 | 370.978 |
| Gross Profit/Loss - EUR | - | 7.268 | 79.743 | 30.177 | 51.838 | 72.394 | 82.190 | 120.190 | 174.625 | 241.893 |
| Net Profit/Loss - EUR | - | 7.118 | 76.902 | 27.401 | 49.306 | 70.373 | 79.224 | 116.204 | 170.357 | 202.231 |
| Employees | - | 7 | 5 | 7 | 8 | 9 | 8 | 6 | 8 | 9 |
Check the financial reports for the company - Oftalmodent Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 307 | 20.453 | 53.953 | 49.764 | 46.841 | 39.256 | 63.744 | 111.615 | 138.575 |
| Current Assets | - | 25.634 | 90.310 | 81.599 | 70.855 | 78.180 | 107.715 | 158.404 | 187.432 | 182.601 |
| Inventories | - | 17.250 | 43.871 | 44.123 | 34.393 | 31.165 | 36.449 | 61.153 | 71.560 | 50.796 |
| Receivables | - | 0 | 17.074 | 12.243 | 1.036 | 1.502 | 3.900 | 25.532 | 71.151 | 97.388 |
| Cash | - | 8.384 | 29.366 | 25.233 | 35.426 | 45.513 | 67.366 | 71.719 | 44.720 | 34.417 |
| Shareholders Funds | - | 7.162 | 83.943 | 28.144 | 53.725 | 74.169 | 89.890 | 122.219 | 183.038 | 209.648 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 18.779 | 33.348 | 110.565 | 68.942 | 52.861 | 57.082 | 99.929 | 116.009 | 85.317 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.212 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Oftalmodent Srl